Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT ...
Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a ...
Complete responses (CR/CRu) on a phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I.
A characteristic feature of Alzheimer's disease may not be the most accurate measure of its severity and progression in patients, according to new research from the University of Pennsylvania and ...
Positron emission tomography (PET) provided objective evidence of response to treatment with tocilizumab (Actemra) in giant cell arteritis, according to a study by researchers from the National ...
PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...
Subtle Medical, a leader in AI-powered medical imaging software, today announced the FDA clearance of SubtleHD™(PET), its next-generation AI-powered PET image enhancement solution designed to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results